Press Release

Excessive Daytime Sleepiness Market: Market Size & Share, Epidemiology Analysis, Patient Pool, Pipeline Therapies, Key Pharma Companies Involved and Emerging Trends

5353 Logo20icrowd 1

DelveInsight’s Excessive Daytime Sleepiness (EDS) Market Insights Report offers a detailed analysis of Disease, its causes, symptoms, diagnostics modalities, and treatment options. 

Excessive Daytime Sleepiness market size, epidemiology, innovative therapies, market drivers, market barriers, ongoing clinical trials, critical collaboration in the room, and key pharmaceutical companies actively moving the market size forward are all covered in-depth in the study.

Some of the key highlights from the Excessive Daytime Sleepiness Market Insights: 

  • The total diagnosed prevalence of EDS in these five disorders (obstructive sleep apnea, bipolar disorder, parkinson’s disease, narcolepsy, idiopathic hypersomnia) in the 7MM was estimated to be 6,295,782 in 2017.
  • In 2017, the highest cases of EDS were diagnosed in the US, compared to EU-5 and Japan.
  • Germany accounts for 30.69% of the total diagnosed prevalent cases of EDS in EU5 in 2017.
  • In the United States, OSA accounts for the bulk of EDS events. Parkinson’s Disease, narcolepsy, and idiopathic hypersomnia are the most common sleep disorders.
  • BenevolentAI Bio, Avadel Pharmaceuticals, Theranexus, Jazz Pharmaceuticals, Axsome Therapeutics, Bioprojet Pharma, Harmony Biosciences, and others are among the companies working on therapies to treat and control Excessive Daytime Sleepiness (EDS). These treatments are in various stages of progress at the moment.
  • Key pipeline therapies in the EDS market include BEN-2001, FT218, Xywav (JZP-258) for EDS in IH, AXS-12 (Reboxetine), Wakix (Pitolisant), and others.

Learn more by requesting for sample @ Excessive Daytime Sleepiness (EDS) Market Landscape

Excessive Daytime Sleepiness (EDS): Overview 

Excessive Daytime Sleepiness is characterized by a struggle to remain awake and alert throughout the day’s main waking episodes, with sleep occurring accidentally or at inopportune times.

EDS is linked to various illnesses, including metabolic, cardiovascular, neurological, and psychological disorders, as well as voluntary habits that signify inadequate sleep and sleep debt, which can lead to impairment and increased mortality risk. EDS is often linked to social and economic implications, making it a severe public health problem. 

For more insights into Excessive Daytime Sleepiness, causes, and treatment, reach out to Excessive Daytime Sleepiness (EDS) Treatment Landscape.

Excessive Daytime Sleepiness Epidemiology Segmentation 

The Excessive Daytime Sleepiness Market report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:

  • Excessive Daytime Sleepiness Prevalence 
  • Age-Specific Excessive Daytime Sleepiness 
  • Gender-Specific Excessive Daytime Sleepiness Prevalence 
  • Excessive Daytime Sleepiness Diagnosed and Treatable Cases

Visit for more @ Excessive Daytime Sleepiness Epidemiological Insights

Excessive Daytime Sleepiness Market

As per DelveInsight, in 2017, the market of EDS was USD 2,587.4 million in the 7MM. The primary need of EDS was estimated by different approved treatments such as Wakix (Pitolisant) and Xyrem (sodium oxybate), Sunosi, etc.

The market is expected to grow by factors like an increase in the patient pool due to a rise in the prevalence of underlying medical conditions, desired entry of emerging therapies, i.e., such as FT218 (Sodium Oxybate) Extended-Release Oral Suspension, JZP-258, BEN-2001, THN102, Wakix (Pitolisant): for OSA, and AXS-12 (Reboxetine), and deeper penetration in the 7MM markets.

Excessive Daytime Sleepiness Pipeline Therapies and Key Companies 

  • BEN-2001:BenevolentAI Bio
  • FT218: Avadel Pharmaceuticals
  • Xywav (JZP-258): Jazz Pharmaceuticals
  • AXS-12 (Reboxetine): Axsome Therapeutics

For more information, visit Excessive Daytime Sleepiness Market Analysis, Patient Pool, and Emerging Therapies

Excessive Daytime Sleepiness Market Drivers 

  • Rising prevalent population
  • Technological advancements
  • Emerging therapies 
  • Extensive R&D

 

Scope of the Report

  • 11 Years Forecast
  • 7MM Coverage 
  • Descriptive overview of Excessive Daytime Sleepiness, covering causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
  • Comprehensive insight into Excessive Daytime Sleepiness epidemiology and treatment in the 7MM
  • Current and emerging therapies for Excessive Daytime Sleepiness
  • Excessive Daytime Sleepiness market drivers and barriers 

Key Questions Answered in the Report

  • What was the Excessive Daytime Sleepiness (EDS) market share (%) distribution in 2017, and how would it look like in 2030?
  • What will be the overall market size and market size by therapies for Excessive Daytime Sleepiness in the 7MM during the forecast period (2017-2030)?
  • What are the market’s main findings, and which country will have the largest Excessive Daytime Sleepiness market size over the forecast period (2017-2030)?
  • At what CAGR, the Excessive Daytime Sleepiness market is expected to grow by 7MM during the forecast period (2017-2030)?

Get in touch with our Business executive @ Excessive Daytime Sleepiness Market Landscape Analysis.

Table of Contents: 

1.  Key Insights
2.  Report Introduction
3.  Competitive Intelligence Analysis for Excessive Daytime Sleepiness
4.  Excessive Daytime Sleepiness Market Overview at a Glance
5.  Executive Summary of Excessive Daytime Sleepiness
6.  Excessive Daytime Sleepiness Epidemiology and Market Methodology
7.  Excessive Daytime Sleepiness Epidemiology and Patient Population
8.  Excessive Daytime Sleepiness Patient Journey
9.  Treatment Algorithm, Current Treatment, and Medical Practices
10. Critical Endpoints in Excessive Daytime Sleepiness Clinical Trials
11.  Excessive Daytime Sleepiness Marketed Therapies
12. Excessive Daytime Sleepiness Emerging Therapies
13. Excessive Daytime Sleepiness: 7 Major Market Analysis
14. Attribute analysis
15. Access and Reimbursement Overview of Excessive Daytime Sleepiness
16.  KOL Reviews
17. Case Reports
18. Excessive Daytime Sleepiness Market Drivers
19. Excessive Daytime Sleepiness Market Barriers
20. SWOT Analysis
21. Disclaimer
22. DelveInsight Capabilities
23. About DelveInsight

Learn more about the report offerings @ Excessive Daytime Sleepiness (EDS) Market Outlook

Related Reports

Obstructive Sleep Apnea Market

DelveInsight’s “Obstructive Sleep Apnea Market Insights, Epidemiology, and Market Forecast – 2030” Report.

Obstructive Sleep Apnea Pipeline

DelveInsight’s “Obstructive Sleep Apnea (OSA) Pipeline Insights, 2021” Report.

Obstructive Sleep Apnea (OSA) Epidemiology

DelveInsight’s “Obstructive Sleep Apnea (OSA) – Epidemiology Forecast to 2030” Report.

Restless Leg Syndrome Market

DelveInsight’s “Restless Leg Syndrome – Market Insights, Epidemiology, and Market Forecast-2030” Report.

Restless Legs Syndrome Pipeline

DelveInsight’s “Restless Legs Syndrome Pipeline Insights, 2021” Report.

Restless Leg Syndrome Epidemiology

DelveInsight’s “Restless Leg Syndrome – Epidemiology Forecast to 2030” Report.

Narcolepsy Market

DelveInsight’s “Narcolepsy–Market Insights, Epidemiology, and Market Forecast-2030” Report.

Narcolepsy Pipeline

DelveInsight’s “Narcolepsy Pipeline Insights, 2021” Report.

Narcolepsy Epidemiology

DelveInsight’s “Narcolepsy – Epidemiology Forecast to 2030” Report.

Insomnia Market Insights

DelveInsight’s “Insomnia – Market Insights, Epidemiology, and Market Forecast-2030” Report.

Insomnia Pipeline

DelveInsight’s “Insomnia Pipeline Insights, 2021” Report.

Insomnia Epidemiology

DelveInsight’s “Insomnia – Epidemiology Forecast to 2030” Report.

Chronic Insomnia Market

DelveInsight’s “Chronic Insomnia—Market Insights, Epidemiology, and Market Forecast—2030” Report.

Chronic Insomnia Epidemiology

DelveInsight’s “Chronic Insomnia – Epidemiology Forecast—2030Report.

Sleep Apnea Market

DelveInsight’s “Sleep Apnea – Market Insights, Epidemiology, and Market Forecast-2030” Report.

Sleep Apnea Pipeline

DelveInsight’s “Sleep Apnea Pipeline Insights, 2021” Report.

Sleep Apnea Epidemiology

DelveInsight’s “Sleep Apnea – Epidemiology Forecast to 2030” Report.

Related Blog:

Sleep Disorders: An Emerging Public Health Issue

Get in touch with our Business executive for Pharma and Healthcare

Market Assessment and Consulting 

About DelveInsight 

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences providing comprehensive end-to-end solutions to improve performance.  

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Tags: excessivedaytimesleepinessmarket, excessivedaytimesleepinessmarkettrends, sleepdisorders, excessivedaytimesleepinessmarketshare, excessivedaytimesleepinesstreatmentmarket

See Campaign: https://www.delveinsight.com/
Contact Information:
Shruti Thakur [email protected] +1(919)321-6187 www.delveinsight.com

Tags:
, Menafn, IPS, Reportedtimes, Extended Distribution, Research Newswire, English

image

Contact Information:

Shruti Thakur
[email protected]
+1(919)321-6187
www.delveinsight.com